Funded Tech Companies
Progentos Therapeutics
Progentos Therapeutics is a healthcare services company, located in Watertown. Venture capital investment was provided by Forbion Capital Partners, Longwood Fund and Mission BioCapital.
Company Overview
Company Name
Progentos Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
200 Dexter Ave
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Progentos is developing a new approach to treating multiple sclerosis that stimulates the body's natural repair mechanisms. The myelin sheath is generated by specialized cells called oligodendrocytes. Progentos aims to develop novel, first in class small-molecule therapeutics to activate oligodendrocyte progenitor cells to regenerate oligodendrocytes and thus replace myelin lost to MS.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/20/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Loose
Chief Marketing Officer
Dana Hilt
Chief Scientific Officer
Sanjay Magavi
Company Investors
- Forbion Capital Partners
- Longwood Fund
- Mission BioCapital
- Alta Partners
- Dolby Family Ventures
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs